BioNTech SE (BNTX) stock
BNTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 10, 2026Score 3/30
$83.26−1.60 (-1.89%)
Close on Nov 18, 2026Market cap $20.92BP/E –Yield –
BioNTech price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
BioNTech's price to sales ratio was 6.9× on Nov 11, 2026, against 7.8× a year earlier. Over the last 5 years it ranged from 1.1× to 117.4×, with a median of 6.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 6.9× | −0.2 |
| 2025 | Dec 31, 2025 | 7.1× | +0.2 |
| 2024 | Dec 31, 2024 | 6.9× | +5.5 |
| 2023 | Dec 29, 2023 | 1.3× | −0.5 |
| 2022 | Dec 30, 2022 | 1.8× | −115.6 |
| 2021 | Dec 31, 2021 | 117.4× | −12.5 |
| 2020 | Dec 31, 2020 | 129.8× | +84.7 |
| 2019 | Dec 31, 2019 | 45.1× | – |
See a number that looks wrong?